The effects of glucocorticoids on neuropathic pain: A review with emphasis on intrathecal methylprednisolone acetate delivery

Anesthesia and Analgesia

Volumn 118, Issue 5, 2014, Pages 1097-1110

  Rijsdijk, Mienke ^a   Van Wijck, Albert J M ^a   Kalkman, Cornelis J ^a   Yaksh, Tony L ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b University of California at San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE ACETATE; ANTIINFLAMMATORY AGENT; DRUG DERIVATIVE; METHYLPREDNISOLONE;

CELL ACTIVATION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; GENE REPRESSION; GLIA CELL; HUMAN; INFLAMMATION; NERVE INJURY; NEUROPATHIC PAIN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; TRANSACTIVATION; TRANSCRIPTION REGULATION; TREATMENT RESPONSE; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; GENETICS; INTRASPINAL DRUG ADMINISTRATION; MALE; NEURALGIA; PATHOPHYSIOLOGY; SEXUAL DEVELOPMENT; TRANSCRIPTION INITIATION;

ANTI-INFLAMMATORY AGENTS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; INJECTIONS, SPINAL; MALE; METHYLPREDNISOLONE; NEURALGIA; SEX CHARACTERISTICS; TRANSCRIPTIONAL ACTIVATION;

EID: 84902145230     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000161     Document Type: Review

References (169)

1. Hench PS, Kendall EC. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 1949;24:181-97.
2. Berg A. Clinical and myelographic studies of conservatively treated cases of lumbar intervertebral disk protrusion. Acta Chir Scand 1952;104:124-9.
3. Lindahl O, Rexed B. Histologic changes in spinal nerve roots of operated cases of sciatica. Acta Orthop Scand 1951;20:215-25.
4. Cappio M. [Sacral epidural administration of hydrocortisone in therapy of lumbar sciatica; study of 80 cases]. Reumatismo 1957;9:60-70.
5. Cho KO. Therapeutic epidural block with a combination of a weak local anesthetic and steroids in management of complicated low back pain. Am Surg 1970;36:303-8.
6. Sehgal AD, Gardner WJ. Corticosteroids administered intradurally for relief of sciatica. Cleve Clin Q 1960;27:198-201.
7. Sehgal AD, Gardner WJ. Place Of Intrathecal Methylprednisolone Acetate In Neurological Disorders. Trans Am Neurol Assoc 1963;88:275-6.
8. Sehgal AD, Tweed DC, Gardner WJ, Foote MK. Laboratory studies after intrathecal corticosteroids: determination of corticosteroids in plasma and cerebrospinal fluid. Arch Neurol 1963;9:64-8.
9. Busillo JM, Cidlowski JA. The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab 2013;24:109-19.
10. Stewart AG. Mediators and receptors in the resolution of inflammation: drug targeting opportunities. Br J Pharmacol 2009;158:933-5.
11. Groeneweg FL, Karst H, de Kloet ER, Joëls M. Rapid non- genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 2011;209:153-67.
12. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax 2000;55:603-13.
13. Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol Cell Biol 2008;28:7309-22.
14. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids- new mechanisms for old drugs. N Engl J Med 2005;353:1711-23.
15. De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 2003;24:488-522.
16. Mao J. Central glucocorticoid receptor: A new role in the cellular mechanisms of neuropathic pain. Rev Neurosci 2005;16:233-8.
17. Lim LH, Pervaiz S. Annexin 1: The new face of an old molecule. FASEB J 2007;21:968-75.
18. Sung B, Wang S, Zhou B, Lim G, Yang L, Zeng Q, Lim JA, Wang JD, Kang JX, Mao J. Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats. Pain 2007;131:121-31.
19. Abbinante-Nissen JM, Simpson LG, Leikauf GD. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 1995;268:L601-L6.
20. Kumari R, Willing LB, Jefferson LS, Simpson IA, Kimball SR. REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade. Biochem Biophys Res Commun 2011;412:644-7.
21. Wang H, Kubica N, Ellisen LW, Jefferson LS, Kimball SR. Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J Biol Chem 2006;281:39128-34.
22. Chapman CR, Tuckett RP, Song CW. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J Pain 2008;9:122-45.
23. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier JP. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum 1996;39:1535-44.
24. Norsted Gregory E, Delaney A, Abdelmoaty S, Bas DB, Codeluppi S, Wigerblad G, Svensson CI. Pentoxifylline and propentofylline prevent proliferation and activation of the mammalian target of rapamycin and mitogen activated protein kinase in cultured spinal astrocytes. J Neurosci Res 2013;91:300-12.
25. Obara I, Tochiki KK, Géranton SM, Carr FB, Lumb BM, Liu Q, Hunt SP. Systemic inhibition of the mammalian target of rapamycin (mTOR) pathway reduces neuropathic pain in mice. Pain 2011;152:2582-95.
26. Xu Q, Fitzsimmons B, Steinauer J, O'Neill A, Newton AC, Hua XY, Yaksh TL. Spinal phosphinositide 3- kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation- induced hyperalgesia. J Neurosci 2011;31:2113-24.
27. Evanson NK, Herman JP, Sakai RR, Krause EG. Nongenomic actions of adrenal steroids in the central nervous system. J Neuroendocrinol 2010;22:846-61.
28. Haller J, Mikics E, Makara GB. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol 2008;29:273-91.
29. Buttgereit F, Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids 2002;67:529-34.
30. Moore FL, Evans SJ. Steroid hormones use non-genomic mechanisms to control brain functions and behaviors: A review of evidence. Brain Behav Evol 1999;54:41-50.
31. Ji RR, Gereau RW 4th, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009;60:135-48.
32. Kalia LV, Gingrich JR, Salter MW. Src in synaptic transmission and plasticity. Oncogene 2004;23:8007-16.
33. Ding Y, Gao ZG, Jacobson KA, Suffredini AF. Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells. J Pharmacol Exp Ther 2010;335:693-702.
34. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart- Bornstein M, O'Shea JJ, Chrousos GP, Bornstein SR. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002;16:61-71.
35. Rijsdijk M, van Wijck AJ, Kalkman CJ, Meulenhoff PC, Grafe MR, Steinauer J, Yaksh TL. Safety assessment and pharmacokinetics of intrathecal methylprednisolone acetate in dogs. Anesthesiology 2012;116:170-81.
36. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992;48:261-8.
37. Wall PD, Devor M. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain 1983;17:321-39.
38. Howe JF, Loeser JD, Calvin WH. Mechanosensitivity of dorsal root ganglia and chronically injured axons: A physiological basis for the radicular pain of nerve root compression. Pain 1977;3:25-41.
39. Liu CN, Wall PD, Ben-Dor E, Michaelis M, Amir R, Devor M. Tactile allodynia in the absence of C-fiber activation: Altered firing properties of DRG neurons following spinal nerve injury. Pain 2000;85:503-21.
40. Wall PD, Waxman S, Basbaum AI. Ongoing activity in peripheral nerve: Injury discharge. Exp Neurol 1974;45:576-89.
41. de Souza Grava AL, Ferrari LF, Defino HL. Cytokine inhibition and time-related influence of inflammatory stimuli on the hyperalgesia induced by the nucleus pulposus. Eur Spine J 2012;21:537-45.
42. Otoshi K, Kikuchi S, Konno S, Sekiguchi M. The reactions of glial cells and endoneurial macrophages in the dorsal root ganglion and their contribution to pain-related behavior after application of nucleus pulposus onto the nerve root in rats. Spine (Phila Pa 1976) 2010;35:264-71.
43. Takebayashi T, Cavanaugh JM, Cüneyt Ozaktay A, Kallakuri S, Chen C. Effect of nucleus pulposus on the neural activity of dorsal root ganglion. Spine (Phila Pa 1976) 2001;26: 940-5.
44. Kim D, You B, Lim H, Lee SJ. Toll-like receptor 2 contributes to chemokine gene expression and macrophage infiltration in the dorsal root ganglia after peripheral nerve injury. Mol Pain 2011;7:74.
45. Obata K, Tsujino H, Yamanaka H, Yi D, Fukuoka T, Hashimoto N, Yonenobu K, Yoshikawa H, Noguchi K. Expression of neurotrophic factors in the dorsal root ganglion in a rat model of lumbar disc herniation. Pain 2002;99:121-32.
46. Takayama B, Sekiguchi M, Yabuki S, Fujita I, Shimada H, Kikuchi S. Gene expression changes in dorsal root ganglion of rat experimental lumber disc herniation models. Spine (Phila Pa 1976) 2008;33:1829-35.
47. Cuéllar JM, Borges PM, Cuéllar VG, Yoo A, Scuderi GJ, Yeomans DC. Cytokine expression in the epidural space: A model of noncompressive disc herniation-induced inflammation. Spine (Phila Pa 1976) 2013;38:17-23.
48. Park HW, Ahn SH, Kim SJ, Seo JM, Cho YW, Jang SH, Hwang SJ, Kwak SY. Changes in spinal cord expression of fractalkine and its receptor in a rat model of disc herniation by autologous nucleus pulposus. Spine (Phila Pa 1976) 2011;36:E753-60.
49. Cuellar JM, Montesano PX, Carstens E. Role of TNF-alpha in sensitization of nociceptive dorsal horn neurons induced by application of nucleus pulposus to L5 dorsal root ganglion in rats. Pain 2004;110:578-87.
50. Olmarker K. Combination of two cytokine inhibitors reduces nucleus pulposus-induced nerve injury more than using each inhibitor separately. Open Orthop J 2011;5:151-3.
51. Watanabe K, Yabuki S, Sekiguchi M, Kikuchi S, Konno S. Etanercept attenuates pain-related behavior following compression of the dorsal root ganglion in the rat. Eur Spine J 2011;20:1877-84.
52. Jin X, Gereau RW 4th. Acute p38-mediated modulation of tetrodotoxin- resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci 2006;26:246-55.
53. Schäfers M, Sommer C, Geis C, Hagenacker T, Vandenabeele P, Sorkin LS. Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro. Neuroscience 2008;157:414-23.
54. Lindå H, Sköld MK, Ochsmann T. Activating transcription factor 3, a useful marker for regenerative response after nerve root injury. Front Neurol 2011;2:30.
55. Nascimento D, Pozza DH, Castro-Lopes JM, Neto FL. Neuronal injury marker ATF-3 is induced in primary afferent neurons of monoarthritic rats. Neurosignals 2011;19:210-21.
56. Rabert D, Xiao Y, Yiangou Y, Kreder D, Sangameswaran L, Segal MR, Hunt CA, Birch R, Anand P. Plasticity of gene expression in injured human dorsal root ganglia revealed by GeneChip oligonucleotide microarrays. J Clin Neurosci 2004;11:289-99.
57. Takeuchi H, Kawaguchi S, Mizuno S, Kirita T, Takebayashi T, Shimozawa K, Torigoe T, Sato N, Yamashita T. Gene expression profile of dorsal root ganglion in a lumbar radiculopathy model. Spine (Phila Pa 1976) 2008;33:2483-8.
58. Dib-Hajj SD, Black JA, Waxman SG. Voltage-gated sodium channels: Therapeutic targets for pain. Pain Med 2009;10: 1260-9.
59. Moldovan M, Alvarez S, Romer Rosberg M, Krarup C. Axonal voltage-gated ion channels as pharmacological targets for pain. Eur J Pharmacol 2013;708:105-12.
60. Wang W, Gu J, Li YQ, Tao YX. Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? Mol Pain 2011;7:16.
61. Romero-Sandoval EA, Horvath RJ, DeLeo JA. Neuroimmune interactions and pain: Focus on glial-modulating targets. Curr Opin Investig Drugs 2008;9:726-34.
62. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007;10:1361-8.
63. Anzai H, Hamba M, Onda A, Konno S, Kikuchi S. Epidural application of nucleus pulposus enhances nociresponses of rat dorsal horn neurons. Spine (Phila Pa 1976) 2002;27:E50-5.
64. Cuellar JM, Montesano PX, Antognini JF, Carstens E. Application of nucleus pulposus to L5 dorsal root ganglion in rats enhances nociceptive dorsal horn neuronal windup. J Neurophysiol 2005;94:35-48.
65. Olmarker K, Størkson R, Berge OG. Pathogenesis of sciatic pain: A study of spontaneous behavior in rats exposed to experimental disc herniation. Spine (Phila Pa 1976) 2002;27:1312-7.
66. Balayssac D, Ferrier J, Descoeur J, Ling B, Pezet D, Eschalier A, Authier N. Chemotherapy-induced peripheral neuropathies: From clinical relevance to preclinical evidence. Expert Opin Drug Saf 2011;10:407-17.
67. Wang XM, Lehky TJ, Brell JM, Dorsey SG. Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine 2012;59:3-9.
68. Garry EM, Delaney A, Anderson HA, Sirinathsinghji EC, Clapp RH, Martin WJ, Kinchington PR, Krah DL, Abbadie C, Fleetwood-Walker SM. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 2005;118:97-111.
69. Kennedy PG, Grinfeld E, Bontems S, Sadzot-Delvaux C. Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia. Virology 2001;289:218-23.
70. Kinchington PR, Goins WF. Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models. J Neurovirol 2011;17:590-9.
71. Stemkowski PL, Smith PA. Sensory neurons, ion channels, inflammation and the onset of neuropathic pain. Can J Neurol Sci 2012;39:416-35.
72. Xu Q, Yaksh TL. A brief comparison of the pathophysiology of inflammatory versus neuropathic pain. Curr Opin Anaesthesiol 2011;24:400-7.
73. Li H, Xie W, Strong JA, Zhang JM. Systemic antiinflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting, and elevation of proinflammatory cytokines in a rat model of neuropathic pain. Anesthesiology 2007;107:469-77.
74. Devor M, Govrin-Lippmann R, Raber P. Corticosteroids suppress ectopic neural discharge originating in experimental neuromas. Pain 1985;22:127-37.
75. Johansson A, Hao J, Sjölund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibres. Acta Anaesthesiol Scand 1990;34:335-8.
76. Johansson A, Dahlin L, Kerns JM. Long-term local corticosteroid application does not influence nerve transmission or structure. Acta Anaesthesiol Scand 1995;39:364-9.
77. Li JY, Xie W, Strong JA, Guo QL, Zhang JM. Mechanical hypersensitivity, sympathetic sprouting, and glial activation are attenuated by local injection of corticosteroid near the lumbar ganglion in a rat model of neuropathic pain. Reg Anesth Pain Med 2011;36:56-62.
78. Jafari M, Seese RR, Babayan AH, Gall CM, Lauterborn JC. Glucocorticoid receptors are localized to dendritic spines and influence local actin signaling. Mol Neurobiol 2012;46:304-15.
79. Tan AM, Chang YW, Zhao P, Hains BC, Waxman SG. Rac1- regulated dendritic spine remodeling contributes to neuropathic pain after peripheral nerve injury. Exp Neurol 2011;232:222-33.
80. Gao YJ, Ji RR. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010;7:482-93.
81. Tsuda M, Masuda T, Tozaki-Saitoh H, Inoue K. Microglial regulation of neuropathic pain. J Pharmacol Sci 2013;121:89-94.
82. Takeda K, Sawamura S, Sekiyama H, Tamai H, Hanaoka K. Effect of methylprednisolone on neuropathic pain and spinal glial activation in rats. Anesthesiology 2004;100:1249-57.
83. Wang QS, Jiang YH, Wang TD, Xiao T, Wang JK. Effects of betamethasone on neuropathic pain in a rat spare nerve injury model. Clin Exp Pharmacol Physiol 2013;40:22-7.
84. Scholz J, Abele A, Marian C, Häussler A, Herbert TA, Woolf CJ, Tegeder I. Low-dose methotrexate reduces peripheral nerve injury-evoked spinal microglial activation and neuropathic pain behavior in rats. Pain 2008;138:130-42.
85. Hayashi R, Xiao W, Kawamoto M, Yuge O, Bennett GJ. Systemic glucocorticoid therapy reduces pain and the number of endoneurial tumor necrosis factor-alpha (TNFalpha)-positive mast cells in rats with a painful peripheral neuropathy. J Pharmacol Sci 2008;106:559-65.
86. Xie W, Liu X, Xuan H, Luo S, Zhao X, Zhou Z, Xu J. Effect of betamethasone on neuropathic pain and cerebral expression of NF-kappaB and cytokines. Neurosci Lett 2006;393:255-9.
87. Ma ZL, Zhang W, Gu XP, Yang WS, Zeng YM. Effects of intrathecal injection of prednisolone acetate on expression of NR2B subunit and nNOS in spinal cord of rats after chronic compression of dorsal root ganglia. Ann Clin Lab Sci 2007;37:349-55.
88. Wang S, Lim G, Zeng Q, Sung B, Ai Y, Guo G, Yang L, Mao J. Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 2004;24:8595-605.
89. Wang S, Lim G, Zeng Q, Sung B, Yang L, Mao J. Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci 2005;25:488-95.
90. Takasaki I, Kurihara T, Saegusa H, Zong S, Tanabe T. Effects of glucocorticoid receptor antagonists on allodynia and hyperalgesia in mouse model of neuropathic pain. Eur J Pharmacol 2005;524:80-3.
91. Wang S, Lim G, Yang L, Sung B, Mao J. Downregulation of spinal glutamate transporter EAAC1 following nerve injury is regulated by central glucocorticoid receptors in rats. Pain 2006;120:78-85.
92. Wang S, Lim G, Mao J, Sung B, Yang L, Mao J. Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid- 1 receptors after peripheral nerve injury in rats. Pain 2007;131:96-105.
93. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009;373:1905-17.
94. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 2002;109:649-57.
95. Mercado N, Hakim A, Kobayashi Y, Meah S, Usmani OS, Chung KF, Barnes PJ, Ito K. Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma. PLoS One 2012;7:e41582.
96. Gu X, Peng L, Yang D, Ma Q, Zheng Y, Liu C, Zhu B, Song L, Sun X, Ma Z. The respective and interaction effects of spinal GRs and MRs on radicular pain induced by chronic compression of the dorsal root ganglion in the rat. Brain Res 2011;1396:88-95.
97. Clatworthy AL, Illich PA, Castro GA, Walters ET. Role of peri- Axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci Lett 1995;184:5-8.
98. Johansson A, Bennett GJ. Effect of local methylprednisolone on pain in a nerve injury model. A pilot study. Reg Anesth 1997;22:59-65.
99. Kingery WS, Agashe GS, Sawamura S, Davies MF, Clark JD, Maze M. Glucocorticoid inhibition of neuropathic hyperalgesia and spinal Fos expression. Anesth Analg 2001;92:476-82.
100. Lee JB, Choi SS, Ahn EH, Hahm KD, Suh JH, Leem JG, Shin JW. Effect of perioperative perineural injection of dexamethasone and bupivacaine on a rat spared nerve injury model. Korean J Pain 2010;23:166-71.
101. Abram SE, Marsala M, Yaksh TL. Analgesic and neurotoxic effects of intrathecal corticosteroids in rats. Anesthesiology 1994;81:1198-205.
102. Mogil JS. Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon. Nat Rev Neurosci 2012;13:859-66.
103. Sorge RE, LaCroix-Fralish ML, Tuttle AH, Sotocinal SG, Austin JS, Ritchie J, Chanda ML, Graham AC, Topham L, Beggs S, Salter MW, Mogil JS. Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci 2011;31:15450-4.
104. Stokes JA, Corr M, Yaksh TL. Spinal toll-like receptor signaling and nociceptive processing: regulatory balance between TIRAP and TRIF cascades mediated by TNF and IFNβ. Pain 2013;154:733-42.
105. Takanami K, Sakamoto H, Matsuda K, Hosokawa K, Nishi M, Prossnitz ER, Kawata M. Expression of G protein-coupled receptor 30 in the spinal somatosensory system. Brain Res 2010;1310:17-28.
106. Koszdin KL, Shen DD, Bernards CM. Spinal cord bioavailability of methylprednisolone after intravenous and intrathecal administration: The role of P-glycoprotein. Anesthesiology 2000;92:156-63.
107. Abu-Mugheisib M, Benecke R, Zettl UK. Management of spasticity in progressive multiple sclerosis: efficacy of repeated intrathecal triamcinolone acetonide administration. Curr Pharm Des 2012;18:4564-9.
108. Nelson DA, Landau WM. Intraspinal steroids: history, efficacy, accidentality, and controversy with review of United States Food and Drug Administration reports. Neurosurg Q 2001;11:276-89.
109. Bani-Hashem N, Hassan-Nasab B, Pour EA, Maleh PA, Nabavi A, Jabbari A. Addition of intrathecal Dexamethasone to Bupivacaine for spinal anesthesia in orthopedic surgery. Saudi J Anaesth 2011;5:382-6.
110. Gardner WJ, Goebert HW Jr, Sehgal AD. Intraspinal corticosteroids in the treatment of sciatica. Trans Am Neurol Assoc 1961;86:214-5.
111. Abram SE. Subarachnoid corticosteroid injection following inadequate response to epidural steroids for sciatica. Anesth Analg 1978;57:313-5.
112. Benzon HT, Chekka K, Darnule A, Chung B, Wille O, Malik K. Evidence-based case report: The prevention and management of postherpetic neuralgia with emphasis on interventional procedures. Reg Anesth Pain Med 2009;34:514-21.
113. Candido KD, Mukalel JJ, Puppala VK, Knezevic NN. Management of postherpetic neuralgia with intrathecal methylprednisolone. Int Anesthesiol Clin 2011;49:88-92.
114. Lu J, Katano T, Nishimura W, Fujiwara S, Miyazaki S, Okasaki I, Aritake K, Urade Y, Minami T, Ito S. Proteomic analysis of cerebrospinal fluid before and after intrathecal injection of steroid into patients with postherpetic pain. Proteomics 2012;12:3105-12.
115. Winnie AP, Hartman JT, Meyers HL Jr, Ramamurthy S, Barangan V. Pain clinic. II. Intradural and extradural corticosteroids for sciatica. Anesth Analg 1972;51:990-1003.
116. Abel R Jr, Nelson DA, Bernat JL. Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces. Del Med J 1977;49:331-43.
117. Bernat JL, Sadowsky CH, Vincent FM, Nordgren RE, Margolis G. Sclerosing spinal pachymeningitis associated with intrathecal methylprednisolone acetate administration for multiple- sclerosis. Neurology 1976;26:351-2.
118. Dougherty JH Jr, Fraser RA. Complications following intraspinal injections of steroids. Report of two cases. J Neurosurg 1978;48:1023-5.
119. Nelson D. Letter: Arachnoiditis from intrathecally given corticosteroids in the treatment of multiple sclerosis. Arch Neurol 1976;33:373.
120. Roberts M, Sheppard GL, McCormick RC. Tuberculous meningitis after intrathecally administered methylprednisolone acetate. JAMA 1967;200:894-6.
121. Shealy CN. Dangers of spinal injections without proper diagnosis. JAMA 1966;197:1104-6.
122. Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999;24:287-93.
123. Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, Yodono M, Asai M, Matsuki A. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000;343:1514-9.
124. Lampe JB, Hindinger C, Reichmann H. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001;344:1019-20.
125. Nelson DA, Landau WM. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001;344:1019.
126. Nelson DA, Landau WM. Intrathecal steroid therapy for postherpetic neuralgia: A review. Expert Rev Neurother 2002;2:631-7.
127. Srinivasan B. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001;344:1021.
128. Zetlaoui PJ, Cosserat J. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001;344:1020-1.
129. Munts AG, van der Plas AA, Ferrari MD, Teepe-Twiss IM, Marinus J, van Hilten JJ. Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome. Eur J Pain 2010;14:523-8.
130. Rijsdijk M, van Wijck AJ, Meulenhoff PC, Kavelaars A, van der Tweel I, Kalkman CJ. No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients. Eur J Pain 2013;17:714-23.
131. Carette S, Leclaire R, Marcoux S, Morin F, Blaise GA, St-Pierre A, Truchon R, Parent F, Levésque J, Bergeron V, Montminy P, Blanchette C. Epidural corticosteroid injections for sciatica due to herniated nucleus pulposus. N Engl J Med 1997;336:1634-40.
132. Koes BW, Scholten RJ, Mens JM, Bouter LM. Efficacy of epidural steroid injections for low-back pain and sciatica: A systematic review of randomized clinical trials. Pain 1995;63:279-88.
133. Cohen SP, Bicket MC, Jamison D, Wilkinson I, Rathmell JP. Epidural steroids: A comprehensive, evidence-based review. Reg Anesth Pain Med 2013;38:175-200.
134. Dawley JD, Moeller-Bertram T, Wallace MS, Patel PM. Intra- Arterial injection in the rat brain: evaluation of steroids used for transforaminal epidurals. Spine (Phila Pa 1976) 2009;34:1638-43.
135. Tiso RL, Cutler T, Catania JA, Whalen K. Adverse central nervous system sequelae after selective transforaminal block: The role of corticosteroids. Spine J 2004;4:468-74.
136. Cicala RS, Turner R, Moran E, Henley R, Wong R, Evans J. Methylprednisolone acetate does not cause inflammatory changes in the epidural space. Anesthesiology 1990;72:556-8.
137. Barros GA, Marques ME, Ganem EM. The effects of intrathecal administration of betamethasone over the dogs' spinal cord and meninges. Acta Cir Bras 2007;22:361-5.
138. Kroin JS, Schaefer RB, Penn RD. Chronic intrathecal administration of dexamethasone sodium phosphate: pharmacokinetics and neurotoxicity in an animal model. Neurosurgery 2000;46:178-82.
139. Latham JM, Fraser RD, Moore RJ, Blumbergs PC, Bogduk N. The pathologic effects of intrathecal betamethasone. Spine (Phila Pa 1976) 1997;22:1558-62.
140. Lima RM, Navarro LH, Carness JM, Barros GA, Marques ME, Solanki D, Ganem EM. Clinical and histological effects of the intrathecal administration of methylprednisolone in dogs. Pain Physician 2010;13:493-501.
141. Donaldson K, Stone V. Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann Ist Super Sanita 2003;39:405-10.
142. Driscoll KE, Carter JM, Hassenbein DG, Howard B. Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect 1997;105 Suppl 5:1159-64.
143. Napierska D, Thomassen LC, Vanaudenaerde B, Luyts K, Lison D, Martens JA, Nemery B, Hoet PH. Cytokine production by co-cultures exposed to monodisperse amorphous silica nanoparticles: The role of size and surface area. Toxicol Lett 2012;211:98-104.
144. Benzon HT, Chew TL, McCarthy RJ, Benzon HA, Walega DR. Comparison of the particle sizes of different steroids and the effect of dilution: A review of the relative neurotoxicities of the steroids. Anesthesiology 2007;106:331-8.
145. Green TR, Fisher J, Stone M, Wroblewski BM, Ingham E. Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 1998;19:2297-302.
146. Lassus J, Waris V, Xu JW, Li TF, Hao J, Nietosvaara Y, Santavirta S, Konttinen YT. Increased interleukin-8 (IL-8) expression is related to aseptic loosening of total hip replacement. Arch Orthop Trauma Surg 2000;120:328-32.
147. Toutain PL, Alvinerie M, Fayolle P, Ruckebusch Y. Bovine plasma and synovial fluid kinetics of methylprednisolone and methylprednisolone acetate after intra-articular administration of methylprednisolone acetate. J Pharmacol Exp Ther 1986;236:794-802.
148. Candido KD, Knezevic I, Mukalel J, Knezevic NN. Enhancing the relative safety of intentional or unintentional intrathecal methylprednisolone administration by removing polyethylene glycol. Anesth Analg 2011;113:1487-9.
149. Borgens RB. Cellular engineering: molecular repair of membranes to rescue cells of the damaged nervous system. Neurosurgery 2001;49:370-8.
150. Krause TL, Bittner GD. Rapid morphological fusion of severed myelinated axons by polyethylene glycol. Proc Natl Acad Sci U S A 1990;87:1471-5.
151. Kim KD, Wright NM. Polyethylene glycol hydrogel spinal sealant (DuraSeal Spinal Sealant) as an adjunct to sutured dural repair in the spine: results of a prospective, multicenter, randomized controlled study. Spine (Phila Pa 1976) 2011;36:1906-12.
152. Benzon HT, Gissen AJ, Strichartz GR, Avram MJ, Covino BG. The effect of polyethylene glycol on mammalian nerve impulses. Anesth Analg 1987;66:553-9.
153. Cole A, Shi R. Prolonged focal application of polyethylene glycol induces conduction block in guinea pig spinal cord white matter. Toxicol In Vitro 2005;19:215-20.
154. Chaubal MV, Kipp J, Rabinow B. Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems. In: Katdar A, Chaubal MV, eds. Excipient Selection Criteria for Injectable Dosage Forms. Ashok Katdare, Mahesh Chaubal: CRC Press. Informa Health Care Inc; 2006:271-90.
155. Zemel E, Loewenstein A, Lazar M, Perlman I. The effects of myristyl gamma-picolinium chloride on the rabbit retina: morphologic observations. Invest Ophthalmol Vis Sci 1993;34:2360-6.
156. Baudouin C. Detrimental effect of preservatives in eyedrops: Implications for the treatment of glaucoma. Acta Ophthalmol 2008;86:716-26.
157. Blakemore WF, Eames RA, Smith KJ, McDonald WI. Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J Neurol Sci 1977;33:31-43.
158. Hall SM, Gregson NA. The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibres of the adult mouse. J Cell Sci 1971;9:769-89.
159. Yezierski RP, Devon RM, Vicedomini JP, Broton JG. Effects of dorsal column demyelination on evoked potentials in nucleus gracilis. J Neurotrauma 1992;9:231-44.
160. Watson CP. A new treatment for postherpetic neuralgia. N Engl J Med 2000;343:1563-5.
161. Meyers C, Lockridge O, La Du BN. Hydrolysis of methylprednisolone acetate by human serum cholinesterase. Drug Metab Dispos 1982;10:279-80.
162. Darreh-Shori T, Soininen H. Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: A review of recent clinical studies. Curr Alzheimer Res 2010;7:67-73.
163. Yaksh TL, Filbert MG, Harris LW, Yamamura HI. Acetylcholinesterase turnover in brain, cerebrospinal fluid and plasma. J Neurochem 1975;25:853-60.
164. Soma LR, Uboh CE, Luo Y, Guan F, Moate PJ, Boston RC. Pharmacokinetics of methylprednisolone acetate after intra- Articular administration and its effect on endogenous hydrocortisone and cortisone secretion in horses. Am J Vet Res 2006;67:654-62.
165. Derendorf H, Möllmann H, Krieg M, Tunn S, Möllmann C, Barth J, Röthig HJ. Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers. Pharm Res 1991;8:263-8.
166. Autefage A, Alvinerie M, Toutain PL. Synovial fluid and plasma kinetics of methylprednisolone and methylprednisolone acetate in horses following intra-articular administration of methylprednisolone acetate. Equine Vet J 1986;18:193-8.
167. Eisenach JC, Shafer SL, Yaksh T. The need for a journal policy on intrathecal, epidural, and perineural administration of non- Approved drugs. Pain 2010;149:417-9.
168. Rowbotham MC. Pain's policy on the spinal administration of drugs. Pain 2010;149:415-6.
169. Yaksh TL, Eisenach JC, Shafer SL. Consent contraindicated? Science 2010;328:45.